CDK4/6 Inhibitors in the First-line Treatment Setting

Dr. Elizabeth Reed and Dr. Cynthia Ma discuss potential clinical benefits of these novel inhibitors in the first-line treatment setting for patients with hormone-receptor-positive breast cancer. E... Author: imedex Added: 03/27/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts